Objectives To investigate the prevalence of hearing loss after cardiac surgery in infancy, patient and operative factors associated with hearing loss, and the relationship of hearing loss to neurodevelopmental outcomes.
C ongenital heart defects (CHDs) are the most common developmental defects and frequently require repair in infancy. As surgical techniques and procedures have improved over the last 25 years, mortality has declined. However, the recognition of neurodevelopmental disabilities as an adverse outcome has increased. [1] [2] [3] Understanding the causes of such morbidities is important in helping to mitigate them and improve long-term outcomes.
Hearing loss in childhood has the potential for life-long neurodevelopmental disability, poor language skills, and behavioral problems. 4 There is a paucity of population-based data regarding the prevalence of hearing loss in preschool age children, but the best estimates are a prevalence of around 1%. 5, 6 Hearing is a prerequisite for learning spoken language and speech production. When these activities are impaired owing to hearing loss, language acquisition is impacted. The Joint Committee on Infant Hearing 2007 identified a series of risk factors associated with hearing loss in childhood. 7 Many of these also occur in children with CHDs, including prolonged intensive care, assisted ventilation, extracorporeal membrane oxygenation (ECMO), and exposure to ototoxic medications. [8] [9] [10] [11] [12] [13] Hearing loss and its impact on neurodevelopmental indicators have not been studied explicitly in children with different types of CHDs, including those undergoing surgical repair.
The overall purposes of this study were to (1) estimate the prevalence of hearing loss after cardiac surgery in infancy, (2) 
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Methods
This study was a prospective observational study intended to evaluate the effects of apolipoprotein E polymorphisms on neurodevelopmental outcomes for preschool-aged patients 4-5 years of age after cardiac surgery in the neonatal and infant periods. Between September 1998 and April 2003, 675 eligible infants underwent cardiac surgery. Twenty-three infants died before consent, the parents of 102 patients declined participation, and 550 (81%) were enrolled.
14 Eligible patients were ≤6 months of age and undergoing surgical treatment of CHDs with cardiopulmonary bypass, with or without deep hypothermic circulatory arrest. Exclusion criteria included (1) multiple congenital anomalies, (2) recognizable genetic or phenotypic syndrome other than chromosome 22q11 microdeletion syndrome, and (3) language other than English spoken in the home. The current study evaluated those patients who completed a standard audiologic evaluation as part of a comprehensive neurodevelopmental evaluation at 4 years of age (2003) (2004) (2005) (2006) (2007) (2008) . The study was approved by the institutional review board at the Children's Hospital of Philadelphia. Informed consent was obtained from parents or guardians.
Audiologic evaluations were conducted using standard pediatric assessment methods based on developmental ability. Thresholds were obtained for pure tone air conduction stimuli at frequencies of 250-8000 Hz in an audiometric booth. Pure tone bone conduction thresholds were obtained when responses to pure tone air conduction signals were poorer than 15 dB hearing loss. Normal hearing sensitivity was defined as response thresholds of ≤15 dB hearing loss. Hearing loss was defined as average pure tone air conduction thresholds of ≥20 dB hearing loss at the following frequencies (500, 1000, 2000), or average pure tone air conduction thresholds of ≥25 dB hearing loss at 2 or more frequencies of >2000 Hz. Hearing loss was further classified as conductive or sensorineural (sensorineural hearing loss [SNHL]); conductive hearing loss was defined as pure tone bone conduction thresholds of ≤15 dB hearing loss and pure tone air conduction responses of ≥10 dB poorer than the pure tone bone conduction thresholds. SNHL occurred when both pure tone air conduction and pure tone bone conduction thresholds were >15 dB hearing loss, and the difference between the two was ≤10 dB. Hearing loss was classified as indeterminate hearing loss if the subject could not complete the pure tone bone conduction testing necessary (masked or unmasked) owing to immaturity or developmental delay, or could only be assessed in a sound field (responses obtained from the better hearing ear, if differences existed between the ears). Degree of hearing loss was determined based on the pure tone average (PTA). Normal hearing sensitivity was defined as PTA between 0 and 15 dB hearing loss. Hearing loss was defined as PTA of >20 dB hearing loss, using the following PTA ranges and descriptors: 21-39 dB hearing loss (mild); 40-54 dB hearing loss (moderate); 55-69 dB hearing loss (moderate to severe); 70-89 dB hearing loss (severe); and ≥90 dB hearing loss (profound). High-frequency hearing loss (HFHL) was defined as confined to the region at ≥2000 Hz, and using the same descriptors for the average of those responses (ie,"mild HFHL").
Patient-related variables (eg, age at testing, sex, race, anthropometric measures) and perioperative variables (eg, age at surgery, bypass support times, hematocrit, duration of stay) were collected from patient records and patient evaluations and laboratory testing. We were not able to quantify exposure to potentially ototoxic medications.
Patients were evaluated by a genetic dysmorphologist. Chromosome analysis and testing for microdeletion of 22q11 were performed as indicated. Results of the genetic evaluations were classified as normal if no genetic or chromosome abnormality was demonstrated, abnormal if a specific diagnosis was confirmed, and suspect if there was evidence of a genetic syndrome that could not be confirmed.
Language was assessed with the Preschool Language Scale-4 (PLS-4), Auditory Comprehension, Expressive Communication, and Total Language Score. 15 The Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III) was used to assess cognition in children and provides a Full-Scale IQ score. 16 To examine executive functioning and attention the NEuro-PSYchology statue test (NEPSY) was used, targeting inhibition and motor persistence (2 components of executive function and attention).
17
Statistical Analyses
Data analysis occurred in 3 distinct phases: a descriptive phase, a prevalence phase, and a risk modeling phase.
Measures of central tendency, variability, and association were computed for all relevant variables, for the group as a whole, and by hearing loss category. Cardiac diagnosis was coded according to a previously described classification incorporating anatomy and perioperative physiology that has been shown to be predictive of perioperative mortality. Class I is defined as 2 ventricles with no aortic arch obstruction, class II as 2 ventricles with aortic arch obstruction, class III as single ventricle with no arch obstruction, and class IV as single ventricle with arch obstruction. 18 Patients with tetralogy of Fallot and transposition of the great arteries are in class I, whereas patients with hypoplastic left heart syndrome or its variants are in class IV.
Prevalence estimates for the presence or absence of hearing loss and by each of 3 identified subtypes (conductive, SNHL, and indeterminate) were computed complete with 95% CIs.
Three different sets of risk models were specified and tested with presence or absence of hearing loss modeled as a dichotomous outcome. A total of 23 standard logistic regression models and 1 contingency table (ECMO/left ventricular assist device) were specified and tested, representing patientrelated, perioperative, and postoperative factors. The single contingency table test for ECMO/left ventricular assist device was necessary owing to low cell counts in several cells. As a followup to these models, the percentage of patients with hearing loss who had ≥1 of these risk factors was calculated and compared with those without.
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Three secondary analyses were conducted using simple linear regression models to test the relationship between hearing loss and language development (PLS-4 Total Language Score), cognition (WPPSI-III Full-Scale IQ score), and attention/executive function (NEPSY Attention/Executive Function score), respectively (Appendix; available at www.jpeds.com). In each case, hearing loss served as the testable covariate, alone and in the presence of 3 confounders (GA, genetic anomaly, postoperative duration of stay). Owing to the non-normative nature of PLS-4 and NEPSY scores, transformations were necessary to make them more amenable for analysis. That is, Box-Cox transformations were used in which PLS-4 score was raised to a power of 2.06, and NEPSY score was raised to a power of 2.23. All data were analyzed using SAS v9.4 (SAS Institute Inc, Cary, NC).
Results
Of the 550 enrolled patients, the 4-year evaluation was completed by 381 of 486 patients (78% of eligible) who were alive and eligible. Baseline characteristics have been previously reported for patients returning for the 4-year evaluation (n = 381), those who did not return (n = 105), and those who died before 4 years of age (n = 64). 19 The only significant difference in baseline characteristics between returning and nonreturning patients was an underrepresentation of African Americans in the returning patients (21% vs 29%). Three hundred forty-eight patients met the entry criteria for the current study. A total of 33 subjects did not receive an audiological examination owing to either missing the hearing evaluation (n = 15) or an inability to complete the evaluation (n = 18). Table I lists a more complete presentation of the entire cohort as well as each subgroup.
A total of 75 of the 348 children enrolled in the current study were diagnosed with hearing loss, resulting in a prevalence estimate of 21.6% (95% CI, 17.2-25.9). The prevalence rates of conductive hearing loss, SNHL, and indeterminate hearing loss were 12.4% (95% CI, 8.8-16.0), 6.9% (95% CI, 4.1-9.7), and 2.3% (95% CI, 0.6-4.0), respectively (Figure) . Of the 75 children with hearing loss, 50 (67.6%) had mild hearing loss. Of the 24 with SNHL, 12 (50%) had moderate to severe hearing loss and 8 (33.3%) had HFHL. Only 18 of the 348 parents (5.23%) had reported a diagnosis of hearing loss in their infants before this evaluation, 10 of whom used hearing technology. This indicates that 80% of those with hearing loss in this cohort had unrecognized and subsequently untreated hearing loss. Deletions of 22q11 were present in 17 subjects (4.9%; 9 with hearing loss [53%]). Hearing loss was present in 3 of 8 subjects who required ECMO (37.5%).
Patient factors associated with the presence or absence of a hearing loss were gestational age (GA; term, P < .01) and presence of a confirmed genetic anomaly (P < .01). Longer postoperative duration of stay (P < .01) was the only perioperative factor associated with hearing loss. No other perioperative factors were found to have a significant relationship with hearing loss. However, when considering an adjusted, multiple covariate model, a significant interaction was observed between confirmed genetic anomaly and postoperative duration of stay (P < .01; Table II lists the covariates tested). The overall prevalence of hearing loss for those with ≥1 of these identified risk factors was 36.7%, compared with 13.8% in those without
The mean PLS-4 Total Language Score for the normal hearing group was 100.8 (SD, 15.4), more than one-half of a standard deviation higher than the Total Language score for subjects with hearing loss at 92.4 (SD, 20.4). Similarly, the average receptive language score of subjects with normal hearing was 101.2 (SD, 15.0) compared with 93.8 (SD, 19.4) for the subjects with hearing loss. Finally, the expressive language scores for the subjects with no hearing loss was 100.1 (SD, 14.0) compared with the 91.9 (SD, 19.2) for children with hearing loss. The presence of hearing loss was associated with worse total language (PLS-4) skills alone (P < .01; R 2 = 0.03), and in the presence of the aforementioned covariates (P < .01; R 2 = 0.16). Furthermore, when examined with unadjusted analyses, Auditory Comprehension and Expressive Communication were significantly lower in subjects with hearing loss than in subjects without hearing loss.
Significant relationships were observed between hearing loss and 2 neurodevelopmental outcomes: WPPSI FS IQ score (P < .01; R 2 = 0.25), and NEPSY attention score (P < .01; R 2 = 0.19) after adjusting for genetic anomaly and postoperative duration of stay Currently recognized risk factors for adverse neurodevelopmental outcomes were tested for an association with hearing loss. Only younger GA, presence of a genetic anomaly, and longer duration of stay were observed to be significantly associated with hearing loss. Therefore, these 3 covariates were included as potential confounders when estimating the relationship between hearing loss and our 3 neurodevelopmental outcomes, PLS-4 Total Language Score, WPPSI FS IQ, and NEPSY Attention score.
Discussion
In this cohort of preschoolers who survived cardiac surgery in infancy, we found the prevalence of hearing loss was 20-fold higher than what is typically seen in this age group. The presence of a genetic anomaly, GA of <37 weeks, and longer postoperative duration of stay were all significantly related to a diagnosis of hearing loss. Importantly, no modifiable operative management factors were associated with an increased risk of hearing loss. A significant interaction was observed between genetic anomaly and postoperative duration of stay. Last, performance measures of cognition, language skills, and attention were all inversely related to an audiologic deficit, after adjustment for genetic anomaly and postoperative duration of stay.
Conductive hearing loss was diagnosed most frequently and typically results from conditions common among children (ie, otitis media). Once treated, hearing is often restored. For children diagnosed with indeterminate hearing loss, a second audiologic evaluation is critical because they could have conductive hearing loss or SNHL. If left untreated, conductive THE JOURNAL OF PEDIATRICS • www.jpeds.com hearing loss can impact speech and language, and SNHL can cause significant delays in academic achievement and emotional development. A proportion of our cohort had a history of ECMO or exposure to ototoxic medications, and both are related to the diagnosis of SNHL. 9, 13, [20] [21] [22] One-third of the study population with SNHL had HFHL, which is typically missed by caregivers. The consequences of this loss may compromise language acquisition because morphologic markers important for speech are perceived at frequencies (1500-1600 Hz) inaudible to those with HFHL. [23] [24] [25] The prevalence of hearing loss among our cohort was related to the presence of a genetic anomaly, younger GA, and postoperative duration of stay, suggesting that a child's likelihood of hearing loss is associated with both innate and extrinsic factors. Among the spectrum of genetic disorders known to cause congenital defects in children, a small proportion concurrently impacts the cardiac and audiologic systems owing to shared developmental origins. 26 Specific mutations resulting in heart defects and hearing loss are undoubtedly heterogeneous and multifactorial. 27 Many of the genetic syndromes that impact children with CHDs (ie, 22q, Down syndrome) are also associated with hearing loss; however, each is the result of a different mutation, and this suggests that numerous genes may be involved in the presence of hearing loss and CHDs. Younger GA is another inherent factor. During the third trimester, the brain undergoes a great deal of maturation, but preterm birth places the immature brain at an increased risk of injury. 28, 29 These insults (ie, periventricular leukomalacia) can be disruptive to the development of the central nervous system and may ultimately impact the auditory system.
Our findings are consistent with the risk indicators listed by the Joint Commission on Infant Hearing, which states that a neonatal intensive care unit stay of >5 days is associated with hearing loss in childhood. During recovery, our cohort spent time in the intensive care unit, an environment plagued with noise of high frequencies and intensities; such stimuli, in excess, contribute to hearing loss. A longer postoperative duration of stay also serves as a proxy for increased exposure to medication and higher mean drug use. 26 In the CHD population, this is particularly relevant to the use of furosemide, an ototoxic agent. 8, 13 Robertson et al described hearing loss in children with CHD, in the presence of a bolus administration of furosemide. Reports have also described a drug's ototoxicity is related to its duration of use and simultaneous noise exposure. 13, 21, 30 It is important to recognize that the onset of hearing loss in this cohort occurred during early language acquisition and, not surprisingly, significantly lower language scores were found. Although most of the hearing loss we diagnosed was mild, this degree of impairment can have an effect on language acquisition; children with bilateral and unilateral hearing loss tend to have lower expressive language scores than their peers.
In our study, the presence of hearing loss was also predictive of cognition scores among preschoolers with CHD. Children with CHD are known to have decreased scores in cognitive examinations, the nature of which is multifactorial. 2, 31, 32 Similarly, children with hearing loss are also known to perform less well on such tests. [33] [34] [35] [36] Cognitive tests are language based and most often administered verbally, relying on a child's ability to use language to answer examination questions. However, when a child's language abilities are diminished, as they often are in children with hearing loss, performance on such tests is impacted. A deficit in spoken and language input owing to hearing loss influences a child's ability to receive new concepts and information. Language skills are diminished by hearing loss, ultimately affecting cognition and verbal IQ.
Hyperactivity, behavior difficulties, and inattention are morbidities known to occur with increased frequencies in survivors of cardiac surgery. Similarly, children with hearing loss must expend more energy to hear and concentrate, and this overexertion can result in disengagement in their learning and ultimately a decline in attention while in the classroom. 37 At times, this population is described as being inattentive and hyperactive, but these behaviors may occur because their hearing THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 192 loss prohibits them from being sufficiently stimulated. 37 In addition to the repercussions of hearing loss, the immaturity of the brain in children with CHDs and associated disruption in the formation of neural pathways can result in the challenges seen in attention. 2 This study has a number of limitations, the first being that we do not know how many of our participants had hearing loss before surgery. We did not collect data on all of the known risk indicators related to the incidence of hearing loss. Information on total exposure to loop diuretics and ototoxic medications, days of assisted mechanical ventilation, and presence of a postnatal infection were not available for our analysis. Additionally, some of the conductive hearing loss seen may have been temporary. DHCA, deep hypothermic circulatory arrest; SEM, standard error of measurement. N = 348, hearing loss (n = 75), no hearing loss (n = 273). ECMO/left ventricular assist device information was not analyzed using a logistic model owing to insufficient cell sizes. For the ECMO/left ventricular assist device, a Fisher exact test was used (P = .37). *Although 2 decimal places are used throughout for editorial consistency, additional decimal places are needed for more accurate specificity and will be provided upon request.
The Joint Committee on Infant Hearing has provided a number of recommendations (eg, all infants screened by 1 month of age, infants with a neonatal intensive care unit stay of >5 days should have auditory brainstem response examination, and if hearing loss is detected early intervention services should begin by 6 months of age) to ensure those with hearing deficits are detected and receive the necessary care. They suggest that infants who have risk indicators for hearing loss undergo at least 1 diagnostic audiologic evaluation by 24-36 months of age, but ideally, newborns would be screened universally before 3 months of age and receive necessary interventions by 6 months of age. 7 In compliance with the American Academy of Pediatrics, the Joint Commission on Infant Hearing also recommends regular surveillance of auditory skills and developmental milestones by their medical provider. 7 Children with CHDs seem to be at an increased risk for hearing loss, further emphasizing the need for early monitoring and intervention.
It is imperative that children who undergo cardiac surgery at <6 months of age undergo at least 1 audiologic evaluation by 24-30 months to evaluate the status of their hearing. 7 When hearing loss is recognized in a timely manner and children receive the necessary support, we have the potential to modify and improve long-term outcomes. ■ 
